A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707).

Block, MS; Suman, VJ; Nevala, WK; Finnes, HD; Schimke, J; Strand, C; Dimou, A; Kottschade, LA; Yan, YY; Reid, JM; Hocum, C; Markovic, S; McWilliams, RR

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索